XPhyto Therapeutics Corp. works with the most promising disrupters in the pharmaceutical industry; accelerates research and technology development; and commercializes products with an entrepreneurial approach and a commitment to efficiency, effectiveness and accessibility. 

Our network spans Europe and North America with companies at the forefront of diagnostics and drug formulations, and universities specializing in research on the use of psychedelics and cannabinoids.

Recent News

Get the atai
Investor’s Kit now.

Compounds

Market Cap

OTCQB: XPHYF

Focus

Social